First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

Active:	Yes
Cancer Type:	Solid Tumor Unknown Primary	NCT ID:	NCT05103046
Trial Phases:	Phase I	Protocol IDs:	UCT03008-001 (primary) NCI-2021-14000
Eligibility:	18 Years and older, Male and Female	Study Type:	Treatment
Study Sponsor:	1200 Pharma, LLC
NCI Full Details:	http://clinicaltrials.gov/show/NCT05103046

Summary

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and
antitumor activity of UCT-03-008 in patients with advanced solid tumors.

Treatment Sites in Georgia

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.